Clinical Trial Update: Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the use of extended-release niacin and fenofibrate for atherogenic dyslipidemia in obese females; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherogenic Dyslipidemia
• Obesity-associated Disorder

Drugs mentioned

• Extended-release niacin + fenofibrate

Snippet

Sponsor: Lewai Sharki Abdulaziz, MSc PhD | Conditions: Atherogenic Dyslipidemia, Obesity Associated Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-10-12